Related references
Note: Only part of the references are listed.A cross-sectional quantitative analysis of the natural history of Farber disease: an ultra-orphan condition with rheumatologic and neurological cardinal disease features
Matthias Zielonka et al.
GENETICS IN MEDICINE (2018)
Sphingolipids and their metabolism in physiology and disease
Yusuf A. Hannun et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2018)
Chronic lung injury and impaired pulmonary function in a mouse model of acid ceramidase deficiency
Fabian P. S. Yu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2018)
Inactivation of ceramide synthase 2 catalytic activity in mice affects transcription of genes involved in lipid metabolism and cell division
Andreas Bickert et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2018)
Acid ceramidase deficiency: Farber disease and SMA-PME
Fabian P. S. Yu et al.
ORPHANET JOURNAL OF RARE DISEASES (2018)
Deletion of MCP-1 Impedes Pathogenesis of Acid Ceramidase Deficiency
Fabian P. S. Yu et al.
SCIENTIFIC REPORTS (2018)
Brain RNA-Seq Profiling of the Mucopolysaccharidosis Type II Mouse Model
Marika Salvalaio et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Acid Ceramidase Deficiency in Mice Results in a Broad Range of Central Nervous System Abnormalities
Jakub Sikora et al.
AMERICAN JOURNAL OF PATHOLOGY (2017)
Acid Ceramidase Deficiency is characterized by a unique plasma cytokine and ceramide profile that is altered by therapy
Shaalee Dworski et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2017)
Atypical Presentation of Infantile-Onset Farber Disease with Novel ASAH1 Mutations
Soo Yeon Kim et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2016)
CXC chemokine receptor-4 signaling limits hepatocyte proliferation after hepatic ischemia-reperfusion in mice
Gregory C. Wilson et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2015)
Innate immune responses in the brain of sphingolipid lysosomal storage diseases
Einat B. Vitner et al.
BIOLOGICAL CHEMISTRY (2015)
Targeted Induction of Ceramide Degradation Leads to Improved Systemic Metabolism and Reduced Hepatic Steatosis
Jonathan Y. Xia et al.
CELL METABOLISM (2015)
Markedly perturbed hematopoiesis in acid ceramidase deficient mice
Shaalee Dworski et al.
HAEMATOLOGICA (2015)
Markedly perturbed hematopoiesis in acid ceramidase deficient mice
Shaalee Dworski et al.
HAEMATOLOGICA (2015)
Mucopolysaccharide diseases: A complex interplay between neuroinflammation, microglial activation and adaptive immunity
Louise D. Archer et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2014)
Systemic ceramide accumulation leads to severe and varied pathological consequences
Abdulfatah M. Alayoubi et al.
EMBO MOLECULAR MEDICINE (2013)
A review on CXCR4/CXCL12 axis in oncology: No place to hide
Urszula M. Domanska et al.
EUROPEAN JOURNAL OF CANCER (2013)
Morbidity and mortality in type B Niemann-Pick disease
Margaret M. McGovern et al.
GENETICS IN MEDICINE (2013)
Gaucher Disease: Transcriptome Analyses Using Microarray or mRNA Sequencing in a Gba1 Mutant Mouse Model Treated with Velaglucerase alfa or Imiglucerase
Nupur Dasgupta et al.
PLOS ONE (2013)
Ceramide synthases at the centre of sphingolipid metabolism and biology
Thomas D. Mullen et al.
BIOCHEMICAL JOURNAL (2012)
A shift in sphingolipid composition from C24 to C16 increases susceptibility to apoptosis in HeLa cells
Takayuki Sassa et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2012)
Neuropathology in Mouse Models of Mucopolysaccharidosis Type I, IIIA and IIIB
Fiona L. Wilkinson et al.
PLOS ONE (2012)
Endosomal/Lysosomal Processing of Gangliosides Affects Neuronal Cholesterol Sequestration in Niemann-Pick Disease Type C
Sharon Zhou et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin
William L. Holland et al.
NATURE MEDICINE (2011)
Familial Lipogranulomatosis (Farber's disease)
G. H. Amirhakimi et al.
CLINICAL GENETICS (2010)
Hepatic Glycosphingolipid Deficiency and Liver Function in Mice
Richard Jennemann et al.
HEPATOLOGY (2010)
c-Myc Is a Nrf2-Interacting Protein that Negatively Regulates Phase II Genes Through Their Electrophile Responsive Elements
Smadar Levy et al.
IUBMB LIFE (2010)
A Critical Role for Ceramide Synthase 2 in Liver Homeostasis I. ALTERATIONS IN LIPID METABOLIC PATHWAYS
Yael Pewzner-Jung et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
A Critical Role for Ceramide Synthase 2 in Liver Homeostasis II. INSIGHTS INTO MOLECULAR CHANGES LEADING TO HEPATOPATHY
Yael Pewzner-Jung et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Sphingosine 1-Phosphate Lyase Deficiency Disrupts Lipid Homeostasis in Liver
Meryem Bektas et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Niemann-Pick disease type C
Marie T. Vanier
ORPHANET JOURNAL OF RARE DISEASES (2010)
Glucocerebrosidase gene-deficient mouse recapitulates Gaucher disease displaying cellular and molecular dysregulation beyond the macrophage
Pramod K. Mistry et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Central role of ceramide biosynthesis in body weight regulation, energy metabolism, and the metabolic syndrome
Guang Yang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2009)
Secondary lipid accumulation in lysosomal disease
Steven U. Walkley et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2009)
Hepatic Stellate Cells Express Functional CXCR4: Role in Stromal Cell-Derived Factor-1α-Mediated Stellate Cell Activation
Feng Hong et al.
HEPATOLOGY (2009)
Acid Sphingomyelinase Deficiency Prevents Diet-induced Hepatic Triacylglycerol Accumulation and Hyperglycemia in Mice
Gergana M. Deevska et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Principles of bioactive lipid signalling: lessons from sphingolipids
Yusuf A. Hannun et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2008)
Farber's disease type IV presenting with cholestasis and neonatal liver failure: Report of two cases
Asha Willis et al.
PEDIATRIC AND DEVELOPMENTAL PATHOLOGY (2008)
Robust expansion of human hepatocytes in Fah-/-/Rag2-/-/Il2rg-/- mice
Hisaya Azuma et al.
NATURE BIOTECHNOLOGY (2007)
Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance
William L. Holland et al.
CELL METABOLISM (2007)
Roles for C16-ceramide and sphingosine 1-phosphate in regulating hepatocyte apoptosis in response to tumor necrosis factor-α
Y Osawa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
A role for sphingolipids in producing the common features of type 2 diabetes, metabolic syndrome X, and Cushing's syndrome
SA Summers et al.
DIABETES (2005)
Acid sphingomyelinase deficiency. Phenotype variability with prevalence of intermediate phenotype in a series of twenty-five Czech and Slovak patients. A multi-approach study
H Pavlu-Pereira et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2005)
Secondary accumulation of gangliosides in lysosomal storage disorders
SU Walkley
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2004)
The complex life of simple sphingolipids
AH Futerman et al.
EMBO REPORTS (2004)
Ceramide content is increased in skeletal muscle from obese insulin-resistant humans
JM Adams et al.
DIABETES (2004)
Farber disease diagnosed after liver transplantation
MK Salo et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2003)
Sphingosine kinase, sphingosine-1-phosphate, and apoptosis
M Maceyka et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2002)
Share Paper
